eP694 - Circulating Bacterial Metabolite Phenylacetaldehyde Inhibits CRC and Potentiates the Effect of 5-Fluorouracil Treatment

Tuesday, June 6, 2023

10:00 AM – 10:05 AM PT

Location: Monitor 13 (Seattle Convention Center)

Speaker(s)

SF

Sylvain Ferrandon, PhD

The Ohio State University Wexner Medical Center

S. Ferrandon, J. Fedro, R. Aoun, S. clinton, M. Kalady, The Ohio State University Wexner Medical Center, Columbus, Ohio, UNITED STATES|C. Kong, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, CHINA|Z. wang, Cleveland Clinic, Cleveland, Ohio, UNITED STATES|H. king, Shanghai Tenth People's Hospital, Shanghai, CHINA|